Selected research
Industry Research
Pet Obesity Management Industry Research Report 2026
Market perspective
The global Pet Obesity Management market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Pet Obesity Management market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Pet Obesity Management market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Pet Obesity Management market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Pet Obesity Management include Zoetis Inc (Pfizer), Novo Nordisk A/S, Vivaldis, Royal Canin, Pedigree Petfoods, Hill's Pet Nutrition, Inc and Auxthera LLC, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Pet Obesity Management market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pet Obesity Management.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pet Obesity Management Market by Company
Zoetis Inc (Pfizer)
Novo Nordisk A/S
Vivaldis
Royal Canin
Pedigree Petfoods
Hill's Pet Nutrition, Inc
Auxthera LLC
Pet Obesity Management Segment by Type
Drugs
Food Supplements
Pet Obesity Management Segment by Application
Pet Specialty Stores
E-commerce
Others
Pet Obesity Management Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Obesity Management market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pet Obesity Management and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Obesity Management.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pet Obesity Management companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Drugs
- Food Supplements
Applications
- Pet Specialty Stores
- E-commerce
- Others
Companies covered
- Zoetis Inc (Pfizer)
- Novo Nordisk A/S
- Vivaldis
- Royal Canin
- Pedigree Petfoods
- Hill's Pet Nutrition, Inc
- Auxthera LLC
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pet Obesity Management by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Drugs
- 2.2.3 Food Supplements
- 2.3 Pet Obesity Management by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pet Specialty Stores
- 2.3.3 E-commerce
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Pet Obesity Management Breakdown Data by Type
- 3.1 Global Pet Obesity Management Historic Market Size by Type (2021-2026)
- 3.2 Global Pet Obesity Management Forecasted Market Size by Type (2027-2032)
4 Pet Obesity Management Breakdown Data by Application
- 4.1 Global Pet Obesity Management Historic Market Size by Application (2021-2026)
- 4.2 Global Pet Obesity Management Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Pet Obesity Management Market Perspective (2021-2032)
- 5.2 Global Pet Obesity Management Growth Trends by Region
- 5.2.1 Global Pet Obesity Management Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Pet Obesity Management Historic Market Size by Region (2021-2026)
- 5.2.3 Pet Obesity Management Forecasted Market Size by Region (2027-2032)
- 5.3 Pet Obesity Management Market Dynamics
- 5.3.1 Pet Obesity Management Industry Trends
- 5.3.2 Pet Obesity Management Market Drivers
- 5.3.3 Pet Obesity Management Market Challenges
- 5.3.4 Pet Obesity Management Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Pet Obesity Management Players by Revenue
- 6.1.1 Global Top Pet Obesity Management Players by Revenue (2021-2026)
- 6.1.2 Global Pet Obesity Management Revenue Market Share by Players (2021-2026)
- 6.2 Global Pet Obesity Management Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Pet Obesity Management Head Office and Area Served
- 6.4 Global Pet Obesity Management Players, Product Type & Application
- 6.5 Global Pet Obesity Management Manufacturers Established Date
- 6.6 Global Pet Obesity Management Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Pet Obesity Management Market Size (2021-2032)
- 7.2 North America Pet Obesity Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Pet Obesity Management Market Size by Country (2021-2026)
- 7.4 North America Pet Obesity Management Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Pet Obesity Management Market Size (2021-2032)
- 8.2 Europe Pet Obesity Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Pet Obesity Management Market Size by Country (2021-2026)
- 8.4 Europe Pet Obesity Management Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Pet Obesity Management Market Size (2021-2032)
- 9.2 Asia-Pacific Pet Obesity Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Pet Obesity Management Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Pet Obesity Management Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Pet Obesity Management Market Size (2021-2032)
- 10.2 South America Pet Obesity Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Pet Obesity Management Market Size by Country (2021-2026)
- 10.4 South America Pet Obesity Management Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Pet Obesity Management Market Size (2021-2032)
- 11.2 Middle East & Africa Pet Obesity Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Pet Obesity Management Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Pet Obesity Management Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Zoetis Inc (Pfizer)
- 12.1.1 Zoetis Inc (Pfizer) Company Information
- 12.1.2 Zoetis Inc (Pfizer) Business Overview
- 12.1.3 Zoetis Inc (Pfizer) Revenue in Pet Obesity Management Business (2021-2026)
- 12.1.4 Zoetis Inc (Pfizer) Pet Obesity Management Product Portfolio
- 12.1.5 Zoetis Inc (Pfizer) Recent Developments
- 12.2 Novo Nordisk A/S
- 12.2.1 Novo Nordisk A/S Company Information
- 12.2.2 Novo Nordisk A/S Business Overview
- 12.2.3 Novo Nordisk A/S Revenue in Pet Obesity Management Business (2021-2026)
- 12.2.4 Novo Nordisk A/S Pet Obesity Management Product Portfolio
- 12.2.5 Novo Nordisk A/S Recent Developments
- 12.3 Vivaldis
- 12.3.1 Vivaldis Company Information
- 12.3.2 Vivaldis Business Overview
- 12.3.3 Vivaldis Revenue in Pet Obesity Management Business (2021-2026)
- 12.3.4 Vivaldis Pet Obesity Management Product Portfolio
- 12.3.5 Vivaldis Recent Developments
- 12.4 Royal Canin
- 12.4.1 Royal Canin Company Information
- 12.4.2 Royal Canin Business Overview
- 12.4.3 Royal Canin Revenue in Pet Obesity Management Business (2021-2026)
- 12.4.4 Royal Canin Pet Obesity Management Product Portfolio
- 12.4.5 Royal Canin Recent Developments
- 12.5 Pedigree Petfoods
- 12.5.1 Pedigree Petfoods Company Information
- 12.5.2 Pedigree Petfoods Business Overview
- 12.5.3 Pedigree Petfoods Revenue in Pet Obesity Management Business (2021-2026)
- 12.5.4 Pedigree Petfoods Pet Obesity Management Product Portfolio
- 12.5.5 Pedigree Petfoods Recent Developments
- 12.6 Hill's Pet Nutrition, Inc
- 12.6.1 Hill's Pet Nutrition, Inc Company Information
- 12.6.2 Hill's Pet Nutrition, Inc Business Overview
- 12.6.3 Hill's Pet Nutrition, Inc Revenue in Pet Obesity Management Business (2021-2026)
- 12.6.4 Hill's Pet Nutrition, Inc Pet Obesity Management Product Portfolio
- 12.6.5 Hill's Pet Nutrition, Inc Recent Developments
- 12.7 Auxthera LLC
- 12.7.1 Auxthera LLC Company Information
- 12.7.2 Auxthera LLC Business Overview
- 12.7.3 Auxthera LLC Revenue in Pet Obesity Management Business (2021-2026)
- 12.7.4 Auxthera LLC Pet Obesity Management Product Portfolio
- 12.7.5 Auxthera LLC Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst